Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output

Liver International

Volumn 35, Issue 5, 2015, Pages 1633-1641

  Dyson, Jessica K ^a   Elsharkawy, Ahmed M ^b   Lamb, Christopher A ^a,c   Al Rifai, Ahmad ^d   Newton, Julia L ^e   Jones, David E ^a,c,e   Hudson, Mark ^a,c  

^a FREEMAN HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^e NIHR Biomedical Research Centre in Ageing   (United Kingdom)

Author keywords

Autonomic dysfunction; Fatigue; Primary sclerosing cholangitis; Quality of life

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; FOLLOW UP; HEART OUTPUT; HEMODYNAMICS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; PARASYMPATHETIC TONE; POPULATION DYNAMICS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; QUALITY OF LIFE; SYMPATHETIC TONE; AUTONOMIC NEUROPATHY; BILIARY CIRRHOSIS; BRIEF PSYCHIATRIC RATING SCALE; CASE CONTROL STUDY; COMPLICATION; HIGH OUTPUT HEART FAILURE; PATHOPHYSIOLOGY; SCLEROSING CHOLANGITIS; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BRIEF PSYCHIATRIC RATING SCALE; CARDIAC OUTPUT, HIGH; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

EID: 84927660952     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12709     Document Type: Article

References (32)

1. Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 2010; 7: 611-9.
2. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011; 54: 173-84.
3. Sinakos E, Lindor K. Treatment options for primary sclerosing cholangitis. Exp Rev Gastroenterol Hepatol 2010; 4: 473-88.
4. Chapman RW. The natural history of primary sclerosing cholangitis. In: Manns MP, Chapman RW, Stiehl A, Wiesner R, eds. Primary Sclerosing Cholangitis. Proceeding of International Falk Workshop. London: Kluwer Academic Publishers, 1997; 55-68.
5. Hale M, Newton JL, Jones DE. Fatigue in primary biliary cirrhosis. BMJ 2013; 345: e7004.
6. Goldblatt J, Taylor PJS, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002; 122: 1235-41.
7. Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2004; 39: 961-8.
8. ter Borg PC, Fekkes D, Vrolijk JM, van Buuren HR. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. BMC Gastroenterol 2005; 5: 11.
9. Gulati R, Radhakrishnan KR, Hupertz V, et al. Health-related quality of life in children with autoimmune liver disease. J Pediatr Gastroenterol Nutr 2013; 57: 444-50.
10. de Valle MB, Rahman M, Lindkvist B, et al. Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2012; 10: 769-75.
11. ter Borg PCJ, van Os E, van den Broek WW, Hansen BE, van Buuren HR. Fluvoxamine for fatigue in primary biliiary cirrhosis and primary sclerosing cholangitis: a randomised control trial. BMC Gastroenterol 2004; 4: 8-16.
12. Newton JL, Gibson JG, Tomlinson M, Wilton K, Jones DEJ. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44: 91-8.
13. Jones DEJ, Newton JL. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther 2007; 25: 471-6.
14. Newton JL, Allen J, Kerr S, Jones DEJ. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 2005; 26: 197-202.
15. Newton JL, Davidson A, Kerr S, et al. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 2007; 19: 125-32.
16. Newton JL, Hudson M, Tachtatzis P, et al. The population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology 2007; 45: 1496-505.
17. Newton JL, Jones DEJ, Henderson E, et al. Fatigue in non-alcoholic fatty liver disease is severe and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008; 57: 807-13.
18. Newton JL, Wilton K, Pairman J, Jones DEJ, Day CP. Fatigue and autonomic dysfunction in non alcoholic fatty liver disease. Clin Autonom Res 2009; 19: 319-26.
19. Fisk J, Ritvo P, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994; 18: S79-83.
20. Johns M. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994; 17: 703-10.
21. Suarez GA. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999; 52: 523-8.
22. Jones DEJ, Newton JL. The complexity of fatigue. Hepatology 2011; 53: 717-8.
23. Newton JL, Allen J, Kerr S, Jones DE. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 2006; 26: 197-202.
24. Newton JL, Okonkwo O, Sutcliffe K, et al. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 2007; 100: 519-26.
25. Newton JL, Pairman J, Sutcliffe K, Wilton K, Jones DEJ. A predictive model for fatigue and its aetiological associations in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2008; 6: 228-33.
26. Mells G, Pells G, Newton JL, et al. The impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC National Study. Hepatology 2013; 58: 273-83.
27. Carbone M, Mells G, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastorenterology 2013; 144: 560-9.
28. Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 351-7.
29. Newton JL, Hollingsworth KG, Taylor R, et al. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential aetiology. Hepatology 2008; 48: 541-9.
30. Hollingsworth KG, Jones DEJ, Taylor R, et al. Impaired cerebral autoregulation in primary biliary cirrhosis - implications for the pathogenesis of cognitive decline. Liver Int 2010; 30: 878-85.
31. Pells G, Mells GF, Carbone M, et al. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC Cohort. J Hepatol 2013; 59: 67-73.
32. Hollingsworth KG, Newton JL, Taylor R, et al. A pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis. Clin Gastroenterol Hepatol 2008; 6: 1041-8.